Labo'Life Belgium

4 trials 4 recruiting Commercial sponsor

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

4 Recruiting

0 Completed trials

2 Countries active

5 Unique IMPs

N/A Results reported

Phase III/IV

Phase IV

Phase III/IV: 1 Phase IV: 3

Top indications

Herpes simplex 1 Oral herpes 1

Top IMPs

DEOXYRIBONUCLEIC ACID, INTERLEUKIN-1, INTERLEUKIN-2, RIBONUCLEIC ACID, SPECIFIC NUCLEIC ACID SNA-EBV, SPECIFIC NUCLEIC ACID SNA-HLA II 1 DEOXYRIBONUCLEIC ACID, RIBONUCLEIC ACID, SPECIFIC NUCLEIC ACID SNA-HER1, SPECIFIC NUCLEIC ACID SNA-HER2, SPECIFIC NUCLEIC ACID SNA-HLA I, SPECIFIC NUCLEIC ACID SNA-HLA II 1 INTERFERON ALFA, CICLOSPORIN A, INTERLEUKIN-1, INTERLEUKIN-2, RIBONUCLEIC ACID, SPECIFIC NUCLEIC ACID SNA-HLA II, SPECIFIC NUCLEIC ACID SNA-PAPI 1 INTERFERON ALFA, DEOXYRIBONUCLEIC ACID, INTERFERON GAMMA, INTERLEUKIN-1, INTERLEUKIN-2, RIBONUCLEIC ACID, SPECIFIC NUCLEIC ACID SNA-XFSA, SPECIFIC NUCLEIC ACID SNA-XFSB, SPECIFIC NUCLEIC ACID SNA-XFSC, RIBONUCLEIC ACID K10, RIBONUCLEIC ACID K30, TUMOR NECROSIS FACTOR-ALPHA 1 INTERFERON ALFA, INTERLEUKIN-1, INTERLEUKIN-2, RIBONUCLEIC ACID, SPECIFIC NUCLEIC ACID SNA-HLA II, SPECIFIC NUCLEIC ACID SNA-VERU 1

All trials

4 total

Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LHERP® in patients with recurrent orofacial herpes infection… Recruiting

2024-514358-56-00 Phase IV 1 country DEOXYRIBONUCLEIC ACID, RIBONUCLEIC ACID, SPECIFIC NUCLEIC ACID SNA-HER1, SPECIFI…
Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LEBV® and 2LXFS® on asthenia in patients with an EBV infecti… Recruiting

2024-514222-24-00 Phase IV 1 country DEOXYRIBONUCLEIC ACID, INTERLEUKIN-1, INTERLEUKIN-2, RIBONUCLEIC ACID, SPECIFIC …
Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LVERU®JUNIOR and 2LVERU® on the treatment of warts. EVAsION … Recruiting

2024-514476-40-00 Phase III/IV 1 country INTERFERON ALFA, INTERLEUKIN-1, INTERLEUKIN-2, RIBONUCLEIC ACID, SPECIFIC NUCLEI…
Randomized, placebo-controlled, double-blind study to evaluate the efficacy of 2LPAPI® on the clearance of high-risk oncogenic HPV genital i… Recruiting

2024-513969-39-00 Phase IV 2 countries INTERFERON ALFA, CICLOSPORIN A, INTERLEUKIN-1, INTERLEUKIN-2, RIBONUCLEIC ACID, …

Showing 1–4 of 4 trials

← All sponsors A–Z